We have observed
5 EP applications
Dóra Andrea Tepfenhárt
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after May 20, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES
CYCLOALKANE CARBOXYLIC ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS
Hydantoine derivatives as CD38 inhibitors
Substituted B-amino acid derivatives as CXCR3 receptor antagonist
SUBSTITUTED ss-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS